GREY:AMRSQ - Post by User
Post by
jthottamon Dec 16, 2021 7:05pm
218 Views
Post# 34238929
Status Update on IBRX and AMRS
Status Update on IBRX and AMRS The following is a recent CNN video of an interview of the Chairman of ImmunityBio (Ticker: IBRX) Patrick Soon-Shiong who is in a joint venture with AMRS for developing a 2nd generation vaccine that has both antibodies (like the mRNA platforms) and T-cells to kill the COVID variants at the source through a GNP manufacturing scale of hundreds of millions of doses which no long requires the cold storage methods and can extend the shelf-life of these vaccines beyond 1 year.
https://www.youtube.com/watch?v=7qqxNfB_6y0
Some key points that is "new info" in this video are:
-
They are going to Phase 3 "next week" in South Africa
-
Out of 60-70 patients tested so far only 2 have been infected since (in line with Pfizer and Moderna efficacies).
-
Manufacturing is nearly ready in both Botswana and South Africa to produce 1Bn doses.
The results are promising and timing and scale of the operation.
I hope that helps to keep you informed and Happy Investing!